First Horizon Advisors, Inc. Fibrogen Inc Transaction History

First Horizon Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$18.57 - $35.68 $6,666 - $12,809	-359 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$37.09 - $48.97 $12,165 - $16,062	-328 Reduced 47.74%	359 $13,000
Q3 2020 Nov 12, 2020	BUY	$40.47 - $45.5 $7,244 - $8,144	179 Added 35.24%	687 $28,000
Q2 2019 Aug 05, 2019	SELL	$35.13 - $55.53 $386 - $610	-11 Reduced 2.12%	508 $0
Q1 2019 Apr 26, 2019	BUY	$42.83 - $59.91 $22,228 - $31,093	519 New	519 $0

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on First Horizon Advisors, Inc. with notifications on news.